Magic mushroom therapy targets deep grief
NCT ID NCT06724289
First seen Mar 11, 2026 · Last updated May 20, 2026 · Updated 11 times
Summary
This early study looks at whether psilocybin, the active ingredient in magic mushrooms, can help people with prolonged grief disorder. Researchers will test if the therapy is practical and acceptable, and measure changes in grief and trauma symptoms. The study involves 12 adults aged 18-65 who have been struggling with grief for a long time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROLONGED GRIEF DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
University of Virginia
RECRUITINGCharlottesville, Virginia, 22903, United States
Conditions
Explore the condition pages connected to this study.